![Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus - Kimura - 2022 - Journal of Diabetes Investigation - Wiley Online Library Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus - Kimura - 2022 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/47f0a964-7420-4666-94db-a32087b0ae7f/jdi13709-fig-0001-m.jpg)
Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus - Kimura - 2022 - Journal of Diabetes Investigation - Wiley Online Library
![URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland](https://pcppharma.de/wp-content/uploads/2022/02/abbildung1.jpg)
URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland
![Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01202-5/MediaObjects/12933_2020_1202_Fig1_HTML.png)
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text
![Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/546_706110/Slide4.jpg)
Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD
![Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN](https://media.cnn.com/api/v1/images/stellar/prod/160324161342-fda-black-box-drugs-metformin.jpg?c=16x9&q=h_270,w_480,c_fill)
Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN
![Metformin-Loaded Polymer-Based Microbubbles/Nanoparticles Generated for the Treatment of Type 2 Diabetes Mellitus | Langmuir Metformin-Loaded Polymer-Based Microbubbles/Nanoparticles Generated for the Treatment of Type 2 Diabetes Mellitus | Langmuir](https://pubs.acs.org/cms/10.1021/acs.langmuir.1c00587/asset/images/medium/la1c00587_0009.gif)
Metformin-Loaded Polymer-Based Microbubbles/Nanoparticles Generated for the Treatment of Type 2 Diabetes Mellitus | Langmuir
![Istanbul, Türkei - 12. Dezember 2022; glucophage (Metformin), ein Medikament zur Behandlung von Typ-2-Diabetes. Schachtel mit 1000 mg Stockfotografie - Alamy Istanbul, Türkei - 12. Dezember 2022; glucophage (Metformin), ein Medikament zur Behandlung von Typ-2-Diabetes. Schachtel mit 1000 mg Stockfotografie - Alamy](https://l450v.alamy.com/450vde/2heryd6/istanbul-turkei-12-dezember-2022-glucophage-metformin-ein-medikament-zur-behandlung-von-typ-2-diabetes-schachtel-mit-1000-mg-2heryd6.jpg)
Istanbul, Türkei - 12. Dezember 2022; glucophage (Metformin), ein Medikament zur Behandlung von Typ-2-Diabetes. Schachtel mit 1000 mg Stockfotografie - Alamy
![Pharmaceuticals | Free Full-Text | Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19 Pharmaceuticals | Free Full-Text | Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01361/article_deploy/html/images/pharmaceuticals-15-01361-g001.png)